Skip to main content
Powel Kazanjian, MD, Infectious Disease, Ann Arbor, MI

PowelHKazanjianMD

Infectious Disease • Ann Arbor, MI

Associate Professor of Medicine, University Mich Medical School

Join to view full profile

Dr. Kazanjian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kazanjian's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    Ann Arbor, MI 48109
    Phone+1 734-936-4000

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1982 - 1984
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1979 - 1982
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1979

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1994 - 2025
  • RI State Medical License
    RI State Medical License 1984 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • What Will Future Historians Say About COVID-19?
    What Will Future Historians Say About COVID-19?March 16th, 2021
  • COVID-19 Is Reshaping Michigan. It’s Not the First Epidemic to Do So
    COVID-19 Is Reshaping Michigan. It’s Not the First Epidemic to Do SoMarch 7th, 2021
  • Why Do Contagious Diseases Evade Eradication?
    Why Do Contagious Diseases Evade Eradication?December 3rd, 2020
  • Join now to see all

Grant Support

  • Tolerated Dose Of CI 1012 In LATE Stage HIV+ PatientsNational Center For Research Resources1999–2000
  • AIDS Patients Treated W/Sargramostim (GMCSF) &Azithromycin To Inhibit M AviumNational Center For Research Resources1998–2000
  • AIDS Therapy With Filgrastim &Rifabutin To Inhibit Ex Vivo Growth Of M AviumNational Center For Research Resources1998–1999
  • Capacity Of Neutrophils From AIDS Patients Treated With Filgrastim And RifabutinNational Center For Research Resources1997
  • Neutrophils In AIDS To Inhibit Ex Vivo Growth Of Opportunistic PathogensNational Center For Research Resources1996

Dr. Powel Kazanjian, Dr. Powel Kazanjian, MD, Dr. P Kazanjian, Dr. Powel H Kazanjian